Activation of glutamate transporters in rods inhibits presynaptic calcium currents.
D027322:Amino Acid Transport System X-AG / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001224:Aspartic Acid / Q000494:pharmacology; D001383:Azetidinecarboxylic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000187:drug effects; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology*; D002478:Cells, Cultured; D003521:Cyclopropanes / Q000494:pharmacology; D026603:D-Aspartic Acid / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D018698:Glutamic Acid / Q000494:pharmacology; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology; D066298:In Vitro Techniques; D007608:Kainic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009431:Neural Conduction / Q000187:drug effects; D009433:Neural Inhibition / Q000187:drug effects; D018408:Patch-Clamp Techniques; D017729:Presynaptic Terminals / Q000187:drug effects*; D011422:Propionates / Q000494:pharmacology; D017948:Retinal Rod Photoreceptor Cells / Q000187:drug effects* / Q000378:metabolism; D014562:Caudata
C114785:2-amino-4-phosphono-propinate; D027322:Amino Acid Transport System X-AG; D000927:Anticonvulsants; D015220:Calcium Channels; D003521:Cyclopropanes; D011422:Propionates; C120673:benzyloxyaspartate; C083095:azetidine-2,4-dicarboxylic acid; C082313:2-(2,3-dicarboxycyclopropyl)glycine; D001224:Aspartic Acid; D018698:Glutamic Acid; D026603:D-Aspartic Acid; C020889:dihydrokainic acid; D001383:Azetidinecarboxylic Acid; D007608:Kainic Acid; D002118:Calcium; D005998:Glycine